Skip to content

Clinical trials

Demyelinating Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20152
20171
20181
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.3
Clene Nanomedicine2
Atara Biotherapeutics1
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases8
Optic Neuritis5
Neuromyelitis Optica4
Multiple Sclerosis3
Myelitis, Transverse3
Recurrence3
Optic Nerve Diseases2
Autoimmune Diseases1
Epstein-Barr Virus Infections1
Inflammation1

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.